[Atlanta, Georgia] – Vernay, a global leader in precision fluid control components, is excited to announce its participation in MEDevice Boston, scheduled for September 25-26, 2024, at the Boston Convention & Exhibition Center, Boston, MA, USA. The Vernay medical team will be located in Hall C, Booth 337, where they will present their innovative product line designed for the medical device industry.
MEDevice Boston is an important gathering for engineers, innovators, and professionals in the MedTech field. The event provides a unique platform to explore the latest advancements in medical technology. Vernay will introduce a variety of precision-engineered fluid control components that are specifically developed to meet the unique demands of medical devices.
“Vernay excels in providing custom-engineered fluid control solutions that offer precision and reliability,” said Andy Woodward, Vice President of Sales & Marketing at Vernay. “We recognize that the medical industry has stringent requirements, and our products are tailored to meet those exacting standards. We’re eager to meet with attendees at MEDevice Boston and discuss how we can support their needs.”
Shawna Krummel, Global Medical Business Unit Manager at Vernay, added, “MEDevice Boston is a critical opportunity for us to connect with our partners and customers in the MedTech industry. We are committed to delivering fluid control solutions that not only meet today’s medical challenges but also anticipate future needs.”
Vernay invites attendees to stop by Hall C, Booth 337, to learn more about the company’s engineering, manufacturing, and testing capabilities and its commitment to developing high-performance solutions for the medical industry.
For more information about Vernay’s latest medical solutions, visit www.vernay.com.
Vernay Laboratories has been a technology leader in the design, development, and manufacture of customized flow-control components since its founding in 1946. The company also formulates its own compounds to address each specific application.
Vernay’s products play a vital role in millions of medical devices, automobiles, and consumer products. Today, the privately held firm produces more than 1 billion components per year, drawing from a library of more than 33,000 elastomeric materials and compound formulations. It operates six plants around the world, in the U.S., the Netherlands, Italy and China. For more information, visit www.vernay.com.
